{
    "type": "ETP",
    "ucits": false,
    "replication_method": "physical",
    "leverage": true,
    "inverse": false,
    "derivatives": false,
    "swaps": false,
    "complex_factors": [
        "Leverage (3x)",
        "Daily rebalancing with compounding effect",
        "High risk profile (Risk indicator 6/7)",
        "Short-term holding recommendation (1 day)"
    ],
    "classification": "complex",
    "supporting_data": "The product is classified as complex under MiFID II due to several key factors: 1) It provides 3x leveraged exposure to the iShares MSCI Japan ETF, which significantly amplifies both potential gains and losses. 2) The product's daily rebalancing mechanism creates a compounding effect that makes longer-term returns unpredictable and potentially divergent from 3x the underlying asset's performance. 3) The risk indicator is classified as 6/7, indicating very high risk. 4) The recommended holding period is just 1 day, suggesting the product is not suitable for long-term investors. 5) The product is not UCITS-compliant, which often correlates with higher complexity. While the replication method is physical (owning the underlying ETF directly with margin), the leverage and compounding effects create significant complexity that would likely be difficult for retail investors to fully understand. The PRIIPs KID and factsheet confirm these characteristics and emphasize the product's suitability only for sophisticated traders who can monitor positions intraday.",
    "confidence": 95,
    "counter_argument": "One might argue that since the product uses physical replication (owning the underlying ETF with margin) rather than synthetic replication with swaps, it should be considered non-complex. However, the leverage factor, compounding effect, and high risk profile outweigh this factor in the MiFID II complexity assessment. The product's structure and risk characteristics align more closely with complex products than with standard ETFs."
}